Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections

doi:10.4254/wjh.v14.i9.1778

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3096)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

160

WORD

HTML

1477

Figures (1-2)

307

Tables (1-5)

164

Sum=2149

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

262

Download

685

Sum=947

Sep 27, 2022 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Sep 27, 2022; 14(9): 1778-1789
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1778

Table 5 Performance of prognostic scoring systems

Prognostic scoring system	Homogeneity	Discriminatory ability	Akaike information criterion
Prognostic scoring system	Likelihood ratio χ²	Linear trend χ²	Akaike information criterion
CGMH	106.05	106.48	9305.48
AJCC 8^th	81.53	94.16	9336.01
Tokyo	93.02	109.45	9324.52
Taipei	18.76	20.41	9396.77

Citation: Lai Y, Lee JC, Hung HC, Wang YC, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Kao CY, Lee WC. Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections. World J Hepatol 2022; 14(9): 1778-1789
URL: https://www.wjgnet.com/1948-5182/full/v14/i9/1778.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i9.1778